Skip to main content
Clinical Trials/NCT03679104
NCT03679104
Completed
Not Applicable

Endoscopic Clips Versus Overstich Suturing System Device for Closure of Mucosotomy After Per-oral Endoscopic Pyloromyotomy (G-POEM)

Institute for Clinical and Experimental Medicine1 site in 1 country40 target enrollmentNovember 1, 2018
ConditionsGastroparesis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gastroparesis
Sponsor
Institute for Clinical and Experimental Medicine
Enrollment
40
Locations
1
Primary Endpoint
Proportion of subjects with successful and safe incision closure.
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Gastric per-oral endoscopic pyloromyotomy (G-POEM) has been assessed as new modality for treatment of refractory gastroparesis. G-POEM is promising method, which is still under investigation as its safety and efficacy has not been established yet. The ideal closure technique in patients undergoing G-POEM needs to be established. Several techniques may be used for endoscopic mucosal closure: endoscopic clips, OTSC (over the scope clips), endo-loop based methods (KING closure) or endoscopic suture.

The aim of this prospective, open-label study is to compare efficacy and safety of two methods for incision closure in patients who undergo G-POEM: endoscopic clips vs. endoscopic suturing system (OverStitch).

Detailed Description

Based on principles of NOTES (natural orifice transluminal endoscopic surgery), a mini-invasive therapeutic procedure such as per-oral endoscopic myotomy (POEM) or gastric per-oral endoscopic pyloromyotomy (G-POEM) have been assessed as new modalities for treatment of oesophageal achalasia or refractory gastroparesis. G-POEM is a new and promising method, which is still under investigation as its safety and efficacy has not been established yet. There are several questions, which need to be answered before G-POEM is considered as a standard clinical procedure. These questions concern, among others, efficacy, safety, technical performance etc. Mucosal incision should be endoscopically closed to prevent leakage into the abdominal cavity. Obtaining adequate mucosal closure is one of the most important steps of the procedure and is essential in avoiding major morbidity. The ideal closure technique in patients undergoing G-POEM needs to be established. Several techniques may be used for endoscopic mucosal closure: endoscopic clips, OTSC clips, endo-loop based methods (KING closure) or endoscopic suture. At present, simple closure with endoscopic clips has been the most frequently described method for mucosal closure in patients undergoing G-POEM. However, as gastric mucosa is thicker compared to the esophagus, where clips are used for POEM without any major problems, several authors have described problems during gastric incision closure - it takes a rather longer time, some clips cannot be placed and in some patients, other closure method had to be used. Thus, endoscopic clips may not be an ideal closure method in the stomach. A platform that replicates a principle of surgical suturing is endoscopic suturing system. The aim of this prospective, open-label study is to compare efficacy and safety of two methods for incision closure in patients who undergo G-POEM: endoscopic clips vs. endoscopic suturing system (OverStitch). Investigators plan to randomize 30-40 patients (15-20 in both arms, ratio 1:1). The assigned closure method will be decided by an endoscopist prior to starting closure.

Registry
clinicaltrials.gov
Start Date
November 1, 2018
End Date
January 26, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
Institute for Clinical and Experimental Medicine
Responsible Party
Principal Investigator
Principal Investigator

Doc. (Ass. prof.) Jan Martinek, MD, PhD, AGAF

Ass. prof.

Institute for Clinical and Experimental Medicine

Eligibility Criteria

Inclusion Criteria

  • Refractory (\> 6 months) and severe (based on a validated total Gastroparesis Cardinal Symptom Index) gastroparesis, with confirmed gastric emptying based on a gastric emptying study: standardized protocol of scintigraphy in all patients (performed less than 6 months prior to enrolment). The total GSCI (Gastroparesis Cardinal Symptom Index) score must be \>2.0
  • Abnormal gastric emptying is defined as retention of Tc-99 m \>60% at 2 h and/or ≥10% of residual activity at 4 h on a standardized sulphur colloid solid-phase gastric emptying study.
  • Abnormal gastric emptying breath test based on a solid normal range determination for the test used (e.g. T1/2 \> 109 min)
  • Severe refractory disease is defined as GCSI \>2.0 and failure or recurrence in patients who received available optimal pharmacological therapies.
  • Persons 18 years or older at the time of signing the informed consent
  • Signed informed consent

Exclusion Criteria

  • No previous attempt with at least one prokinetic drug
  • No previous attempt to withdraw anticholinergic agents and glucagon like peptide -1 (GLP-1) and amylin analogues in patients treated with these substances
  • Active treatment with opioids or a history of treatment with opioids within 12 months before enrolment
  • Previous gastric surgery (Billroth I or Billroth II)
  • Known eosinophilic gastroenteritis
  • Organic pyloric (or intestinal) obstruction (fibrotic stricture, etc.)
  • Sever coagulopathy
  • Oesophageal or gastric varices and /or portal gastropathy
  • Advanced liver cirrhosis (Child B or Child C)
  • Active peptic ulcer disease

Outcomes

Primary Outcomes

Proportion of subjects with successful and safe incision closure.

Time Frame: 3 months

Definition of successful closure: endoscopically completely closed incision, no need to use another "rescue" closure method, no leak on post-operative day 1, no leak related complications, no readmission due to closure dehiscence, no need for surgery due to closure.

Secondary Outcomes

  • Easiness of the closure(3 months)
  • Mortality at 3 months(3 months)
  • Readmission within 30 days(30 days)
  • Closure time of mucosotomy(1 day)
  • Cost(3 months)
  • Healing quality(3 months)

Study Sites (1)

Loading locations...

Similar Trials